AMETEK MOCON Launches New AMECare® Performance Services Program for USA Permeation Instruments

Monday, June 3, 2019 MINNEAPOLIS, MN, JUNE 2019 – AMETEK MOCON, the global leader in permeation analyzers, testing, and services has launched a new service program – AMECare® Performance Services — for all USA customers who own MOCON permeation instruments.  The new AMECare Performance Services Program was created to provide a holistic suite of services... Read more

908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers

BOSTON, June 3, 2019 — 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced several advancements to their ZipChip® product line, which build upon its industry-leading biotherapeutic analysis capabilities in multiple critical application areas. These product and application expansions will be showcased at the 67th Annual ASMS Conference being held in... Read more

IDEX Corporation Closes Five-Year $800 Million Senior Revolving Credit Facility

May 31, 2019 at 4:05 PM EDTPDF Version LAKE FOREST, Ill.–(BUSINESS WIRE)–May 31, 2019– IDEX CORPORATION (NYSE: IEX) announced today that it has closed a new five-year, $800 million senior revolving credit facility. The facility was financed through a syndication of 9 financial institutions, co–led by Bank of America, N.A., JP Morgan Chase Bank, N.A., and Wells Fargo Bank, National Association, with HSBC Bank... Read more

Tecan successfully completes the acquisition of supplier of key parts

Männedorf, Switzerland, May 31, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of a supplier of key parts. On March 22, 2019, Tecan announced the acquisition of a long-term supplier to vertically integrate the manufacturing of critical precision-machined parts. With two manufacturing sites, one in California,... Read more

Promega launches Microsatellite Instability (MSI) educational resource in front of 2019 American Society of Clinical Oncology (ASCO) annual meeting

Madison, WI USA. (May 31, 2019) Oncology researchers and clinicians seeking to deepen their understanding of Microsatellite Instability (MSI) have a new resource that gathers a wealth of information in one place, including the importance of MSI as a biomarker and methods of detection. Promega Corporation launched its MSI educational website Promega.com/MSIweb this week ahead of this weekend’s... Read more

Waters Novel Cyclic IMS and New SYNAPT XS Lead Full Portfolio of Mass Spectrometry Innovations at ASMS

First-of-its-Kind Cyclic IMS Provides Unlimited Experimental Opportunities while the Research-Grade SYNAPT XS Brings Analytical Flexibility MILFORD, Mass.–(BUSINESS WIRE)–May 30, 2019– Waters Corporation (NYSE:WAT) today unveiled two new high resolution mass spectrometry systems addressing the most challenging analytical needs of leading R&D scientists at the 67th Conference on Mass Spectrometry and Allied Topics (ASMS), June 2 – 6 in Atlanta. This press release... Read more

NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports

Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE, May 30, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced commercial partnerships with three Contract Research Organizations (CROs), including Covance, NeoGenomics Laboratories,... Read more

Smiths Detection technology to be deployed in multi-member-state security initiative sponsored by the European Commission

LONDON, UK — 30 May 2019 Smiths Detection’s advanced explosives and chemical trace-detection technology is to be deployed in a broad security initiative that was launched today by the European Commission. Smiths Detection has leased equipment to be used in coordinated, operational trials in public spaces – including transport and other high-risk targets – in multiple European... Read more